Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Candida albicans recognition receptors represent a complex network of immune sensors that identify fungal cell wall components and proteins to initiate a host defense. This group includes innate pattern recognition receptors (PRRs) such as Dectin-1 (CLEC7A), which binds beta-1,3-glucans, and Dectin-2 (CLEC6A) and Mincle (CLEC4E), which recognize alpha-mannans (Gow et al., 2012, Nature Reviews Microbiology). Toll-like receptors, specifically TLR2 and TLR4, also contribute by sensing phospholipomannans and O-linked mannans (Netea et al., 2008, Trends in Immunology). Furthermore, the adaptive immune system utilizes B-cell receptors (BCRs) and T-cell receptors (TCRs) to recognize specific fungal epitopes like the Als3 adhesin, which is a primary target for vaccine development (Edwards et al., 2018, Clinical Infectious Diseases). These receptors collectively orchestrate phagocytosis, the respiratory burst, and the secretion of critical cytokines such as IL-6, IL-23, and IL-17, which are vital for clearing fungal infections. Therapeutic strategies targeting these receptors include immunomodulators like beta-glucans and vaccines designed to enhance protective Th1/Th17 responses in immunocompromised individuals.
Activation of innate pattern recognition receptors and adaptive antigen receptors to stimulate antifungal effector functions, including Th17 differentiation and antibody production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candida albicans recognition receptors.